Where flaxseed oil is permitted, and what the file must show
Flaxseed oil is a conventional food ingredient, and in the EU, the US and the UK it reaches the market as a food or food-supplement ingredient rather than as a novel food or an additive. The supplement framework, contaminant limits, allergen list and claim rules differ by market; the file has to show the source and release data before the label is designed.
The oil is accepted in all three markets; the file, the limits and the label wording are what change.
Three questions the file has to answer
Compliance work reduces to three questions. Is the substance permitted in the market and dose form? Does the form need an authorisation or a novel-food assessment? What must the label and the file show? For flaxseed oil the first two are quick; most of the work sits in the third.
Flaxseed oil is a food ingredient, not an E-numbered additive, so the additive lists do not apply; it is not a novel food in the EU because it has a documented history of consumption before 15 May 1997. The powder adds the carrier: modified starch is a food ingredient with its own uses and must be declared, so a file that covers only the oil is incomplete.
European Union
Food supplements are governed by Directive 2002/46/EC, which harmonises vitamins and minerals and leaves other substances, including plant oils, to national rules. A flaxseed oil supplement relies on the member state's implementation and on mutual recognition under Regulation (EU) 2019/515, so the national list for the market of sale should be checked.
Contaminants are harmonised by Regulation (EU) 2023/915, which replaced Regulation (EC) No 1881/2006 and took effect on 25 May 2023; it sets maximum levels for lead, cadmium and mercury in food supplements and separate limits for oils and fats. Labelling follows Regulation (EU) No 1169/2011, including the ingredient list, nutrition declaration and allergens. Flaxseed is not on Annex II, so the oil does not trigger an allergen declaration; the carrier still has to be assessed. Claims fall under Regulation (EC) No 1924/2006: only a register entry used with its stated conditions is permitted. Check the current text before the label is signed.
United States
Flaxseed oil is sold as a dietary ingredient under DSHEA on a pre-1994 history of use, not a new-dietary-ingredient notification. The site has to meet the dietary-supplement cGMP in 21 CFR 111, and the product carries a Supplement Facts panel under 21 CFR 101.36. ALA is declared by amount per serving; there is no Daily Value, so no percentage is printed for it.
A structure/function claim needs substantiation and a notification to the FDA within 30 days of marketing, under 21 CFR 101.93; a disease claim is not permitted. There is no federal maximum for heavy metals in supplements. The practical gate is state law, chiefly California's Proposition 65, where lead has a maximum allowable dose level of 0.5 µg per day. A lot that meets the EU panel can still need a Prop 65 assessment.
United Kingdom
Great Britain applies retained food-supplement rules built on the Food Supplements (England) Regulations 2003 and their equivalents in Scotland and Wales. The lists started from the EU position but are now maintained separately, so read the GB text as it stands. Northern Ireland continues to apply EU food law under the Windsor Framework, so a single UK launch can face two rule sets. Claims in GB follow the Nutrition and Health Claims (England) Regulations 2007 and the retained register.
The contaminant panel and the catalog limits
| Metal | EU food supplement | US dietary supplement | UK (GB) | Catalog limit |
|---|---|---|---|---|
| Lead (Pb) | 3.0 mg/kg | No federal maximum; Prop 65 applies | 3.0 mg/kg | ≤3 mg/kg |
| Cadmium (Cd) | 1.0 mg/kg | No federal maximum | 1.0 mg/kg | ≤1 mg/kg |
| Mercury (Hg) | 0.1 mg/kg | No federal maximum | 0.1 mg/kg | ≤0.1 mg/kg |
| Arsenic (As) | No harmonised supplement maximum | No federal maximum | No harmonised maximum | ≤2 mg/kg |
The catalog panel is written against the food-supplement limits, not the oil limits. Regulation (EU) 2023/915 sets lower levels for some metals in oils and fats than in supplements, so the 50% oil fraction can fail a bulk-oil gate while the powder passes the supplement gate. A buyer using the powder in a conventional food should ask which limit applies. Arsenic has no harmonised EU maximum; the 2 mg/kg line is a specification limit.
Where the claim line sits
No disease claim is permitted in any of the three markets. In the EU and the UK a claim must come from the authorised register and meet its conditions; in the US a structure/function claim needs substantiation and the 30-day notification. The ALA content is a nutrient declaration, not a claim, and the two should not be confused in the artwork.
This page reproduces no claim text and makes no claim for the ingredient. The test for a draft label is whether every sentence can be tied to a register entry or a notified statement, with the amount and population that the entry requires.
The file a buyer should hold
| Document | What it must show | Why it is needed |
|---|---|---|
| Certificate of analysis | Lot results, methods, limits, micro and metals | Release evidence for the lot |
| Technical data sheet | Oil load, ALA, carrier, mesh, pack, storage | The specification in usable form |
| Agreed specification | The limits the lot was released against | Comparison between suppliers |
| Source and allergen statement | Botanical source, plant part, allergen assessment | Ingredient list and Annex II review |
| Carrier and antioxidant declaration | Name and level of each | Label declaration and stability |
| GC chromatogram and oxidation data | ALA peak, column, standard, PV and p-AV | Identity and freshness evidence |
| Lot trace and manufacturing site | Lot code, site, date of manufacture | Recall and audit trail |
The certificate is the document most often read alone and least often sufficient. Read it with the specification, the source statement and the chromatogram, because each answers a question the others leave open.
Release checklist before the label is signed
| Check | Evidence |
|---|---|
| Ingredient permitted in the market and dose form | Framework note citing the instrument |
| Botanical source and plant part named | Source statement from the manufacturer |
| Allergen assessment complete | Annex II review, including the carrier |
| Heavy metals inside the applicable limit | COA results by ICP-MS |
| Oxidation inside the agreed limit | PV and p-AV by named methods |
| Nutrition declaration drafted from measured values | ALA on the powder, oil load, serving size |
| Every claim traced to a register or a notification | Claim file with the entry reference |
The market framework is set out on the EU, US and UK regulatory pages; the allergen list is explained in the Annex II glossary entry and the California rule in the Prop 65 entry. The lot data is on the COA page, and the catalog specification on the flaxseed oil powder product page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation